Core One Labs Announces Successful Proof-of-Concept for Biosynthetic N-methyltryptamine (NMT) Mar 3, 2022 03:00AM
Core One Labs’ Files Milestone Patent for Protection of its Recombinant Production System for Optimized Biosynthetic N-methyltryptamine (NMT) Feb 21, 2022 04:00PM
Core One Labs Expects Imminent Breakthrough to Produce NMT, Precursor to DMT Feb 10, 2022 03:00AM
Core One Labs Announces Successful Proof of Concept and Files Patent for Protection of its Recombinant Production System for Optimized Biosynthesis of Psilocybin Jan 21, 2022 04:22PM
Core One Labs Now Also Working to Biosynthesize DMT and Receives License Jan 8, 2022 06:55PM


Oct 16, 2021 09:00PM Core One Labs Applauds the City of Seattle in Their Efforts to Decriminalize Psylocibin and Other Natural Occuring Entheogenic Drugs